PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 118 filers reported holding PROVENTION BIO INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $27,552,518 | +233.6% | 1,143,258 | +46.3% | 0.01% | +500.0% |
Q4 2022 | $8,259,514 | +344.3% | 781,411 | +89.1% | 0.00% | – |
Q3 2022 | $1,859,000 | +85.9% | 413,240 | +65.2% | 0.00% | – |
Q2 2022 | $1,000,000 | -54.8% | 250,198 | -17.3% | 0.00% | – |
Q1 2022 | $2,213,000 | -26.3% | 302,398 | -43.4% | 0.00% | – |
Q4 2021 | $3,004,000 | +1.6% | 534,630 | +15.7% | 0.00% | – |
Q3 2021 | $2,957,000 | -36.9% | 462,076 | -16.9% | 0.00% | – |
Q2 2021 | $4,686,000 | -8.7% | 555,974 | +13.6% | 0.00% | – |
Q1 2021 | $5,135,000 | -43.0% | 489,314 | -8.0% | 0.00% | -100.0% |
Q4 2020 | $9,008,000 | +88.2% | 531,854 | +42.6% | 0.00% | – |
Q3 2020 | $4,786,000 | -33.4% | 372,946 | -26.8% | 0.00% | -100.0% |
Q2 2020 | $7,186,000 | +75.8% | 509,298 | +14.6% | 0.00% | 0.0% |
Q1 2020 | $4,088,000 | -13.6% | 444,401 | +40.0% | 0.00% | 0.0% |
Q4 2019 | $4,730,000 | +557.9% | 317,452 | +200.9% | 0.00% | – |
Q3 2019 | $719,000 | -20.0% | 105,486 | +41.9% | 0.00% | – |
Q2 2019 | $899,000 | – | 74,321 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |